期刊文献+

经阴道补充雌激素对促排卵期薄型子宫内膜的影响 被引量:7

下载PDF
导出
摘要 目的:研究经阴道补充雌激素对促排卵期薄型子宫内膜的影响。方法:选择我院2013年6月~2014年6月接收的不孕症妇女229例作为研究对象,将患者分为四组,A、B、C、D组,分别为57例、56例、66例和50例,其中D组应用克罗米芬(CC)促排卵,A组应用CC+补佳乐,B组应用CC+芬吗通,C组应用CC+补佳乐+芬吗通,比较四组子宫内膜厚度变化、雌激素变化和妊娠率。结果:A、B、C三组妇女治疗后的子宫内膜厚度、雌激素水平、妊娠率显著大于D组,C组治疗后子宫内膜厚度增幅、雌激素水平增幅、妊娠率显著比A、B组大,差异有统计学意义(P〈0.05)。结论:经阴道补充雌激素可改善子宫内膜的容受性,促进胚胎着床,改善不孕症状。 Objective: to study the transvaginal supplement estrogen effects on promoting ovulation thin endometrium.Methods: from June 2013 to June 2014, received 115 cases of infertility women as the research object, the patients can be divided into four groups, group A, B, C, D, respectively, for example, 28, 29 cases, 32 cases and 26 cases ,Finn (CC) of which the application D group g club stimulate ovulation, and A set of application CC + complement jiale, group B application CC + Mr Tong, application of CC group C + complement jiale + Mr Tong, CC group D application, four groups of women in comparison endometrial thickness changes, estrogen and pregnancy rate.Results: Endometrial thickness A, B, C three groups of women after treatment, estrogen levels, the pregnancy rate was significantly h igher than in group D, group C after treatment of endometrial thickness increase in women, estrogen levels increase in pregnancy rate was significantly more than A , group B major, the difference was statistically significant (P〈0.05).Conclusion: transvaginal supplement estrogen can improve receptive endometrium, promote the embryo implantation, improve the symptoms of infertility.
出处 《北方药学》 2016年第5期25-26,共2页 Journal of North Pharmacy
关键词 经阴道补充雌激素 子宫内膜 影响 Vaginal estrogen Endometrium Influence
  • 相关文献

参考文献4

二级参考文献50

  • 1余兰,王树玉,贾婵维,任国庆,马延敏,张军,刘英,兰永连.冷冻胚胎解冻复苏的影响因素[J].中国优生与遗传杂志,2006,14(8):90-91. 被引量:10
  • 2Simon C, Martin JC, Pellicer A. Paracrine regulators of implantation. Baillieres Best Pract Res Clin Obstet Gynaecol, 2000, 14(5):815-26.
  • 3Nikas G, Psychoyos A. Uterine pinopodes in periimplantation human endometrium Clinical relevance. Ann NY Acad Sci, 1997, 816(1):129-42.
  • 4Rigg LA, Hermann H, Yen SSC. Absorption of estrogens from vaginal creams. N Engl J Med, 1978, 298:195-7.
  • 5Mattson L, Cullberg G. Vaginal absorption of two estriol preparation. Acta Obstet Gynecol Scand, 1983, 62(5):393-6.
  • 6Gonen Y, Casper RF. Prediction of implantation by the sonographic appearance of the endometrium during controled ovarian stimulation for in vitro fertilization. J In Vitro Fertil Embryo Transf, 1990, 7(3): 146-52.
  • 7Dechaud H, Bessueille E, Bousquet PJ, et al. Optimal timing of ultrasonographic and doppler evaluation of uterine recep- tivity to implantation. Reprod Biomed Online, 2008, 16(3): 368-75.
  • 8Schild RL, Knobloch C, Dorn C, et al. Endometrial receptivity in an in vitro fertilization program as assessed by spiral artery blood flow, endometrial thickness, endometrial volume, and uterine artery blood flow. Fertil Steril, 2001,75(2):361-6.
  • 9Alexander NJ, Baker E, Kaptein M, et al.Why consider vaginal drug administration. Fertil Steril, 2004, 82(1): 1-12.
  • 10Victoria LH, Kevin EB, William WJ, et al. Vaginal administra- tion of low-dose conjugated estrogens:systemic absorption and effects on the endometrium. Obstet Gynecol, 1994, 84(2):215-8.

共引文献105

同被引文献94

引证文献7

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部